# Topical "Non-Aromatic Very Rich in Steranes" (NAVS) Naphthalan for the Treatment of Oral Mucosal Diseases

> **NCT02920658** · PHASE2 · COMPLETED · sponsor: **Ivan Alajbeg** · enrollment: 57 (actual)

## Conditions studied

- Oral Lichen Planus
- Recurrent Aphthous Stomatitis

## Interventions

- **DRUG:** NAVS Naphthalan
- **DRUG:** 0.05% Betamethasone dipropionate

## Key facts

- **NCT ID:** NCT02920658
- **Lead sponsor:** Ivan Alajbeg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2016-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02920658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02920658, "Topical "Non-Aromatic Very Rich in Steranes" (NAVS) Naphthalan for the Treatment of Oral Mucosal Diseases". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02920658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*